- TRY43.26bn
- TRY42.32bn
- TRY64.83bn
- 62
- 64
- 86
- 84
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10,211 | 10,145 | 15,893 | 71,288 | 64,835 |
Cost of Revenue | |||||
Gross Profit | 957 | 912 | 1,438 | 3,858 | 4,963 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9,846 | 9,834 | 15,475 | 71,315 | 64,623 |
Operating Profit | 365 | 311 | 418 | -27.6 | 211 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 306 | 31 | 697 | 6,494 | 5,466 |
Provision for Income Taxes | |||||
Net Income After Taxes | 273 | -24.9 | 627 | 6,526 | 5,541 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 273 | -24.9 | 670 | 6,848 | 5,954 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 273 | -24.9 | 670 | 6,848 | 5,954 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.906 | -0.253 | 2.35 | 31.3 | 27 |
Dividends per Share |